We often talk about how laboratory professionals make strides for patients within the industry. Lab Week recognizes the importance of transparency involving what goes on in the lab, as well as understanding the tireless work accomplished by our researchers and experts.
Our HI*PRA values of Passion, Human-Centricity, and Integrity touch every area of our work, including the laboratory. PRA works hard to represent everyone while researching treatments and developing drugs. These values allow PRA to make continued bioanalytical advances that keep us at the forefront of laboratory technology. The experts in PRA’s Bioanalytical Laboratories use a patient-centric approach to ensure that their work reflects what patients need and bring that advocacy to the lab.
How Patient Advocacy Improves Laboratory Practices
Patient advocacy and care should be top of mind at every step of drug development, from planning to testing to marketing. It informs every part of PRA’s work, giving laboratory experts the tools necessary for the most effective clinical trials and solutions for patients.
PRA works to collaborate with patient advocacy groups to make treatments more available and accessible globally. PRA also advocates with its partners and within PRA to ensure that more voices get heard. This level of diligence allows us to uphold our HI*PRA values and use our exceptional agility to pivot when necessary to serve a wider community.
PRA’s laboratory professionals work with other areas and departments at PRA so that everyone has a complete picture of the drug development process. Advocacy means bringing ideas and voices beyond a single room or department. It’s about spreading information so that everyone is on the same page and receives the resources they need.
Patient advocacy from experts helps patients’ voices reach inside the industry. PRA aims to improve lives, meaning improving laboratory practices and making changes that help us help patients. Advocacy remains critical for every disease, and Lab Week recognizes the professionals in our industry who draw attention and resources to diseases and patient needs.
PRA’s Role in Bioanalytical Advancement
The oncology field shows us how bioanalysis is critical to cancer research, advancement, and treatment. We must understand biomarkers so that the industry can target specific therapies with different patients, depending on their particular needs. No disease is one-size-fits-all, least of all cancer. Identifying and using our knowledge of biomarkers leads to drug discovery, improves therapy for patients, and creates more successful treatments. The Bioanalytical Laboratory uses the latest technology to locate and use biomarkers for research advancement,.
Bioanalysis involves a combination of discovery, validation, and translation as a process to focus on biomarkers in the industry. In other words, lab experts advocate to bring them into a more expansive space so that we can continue studying and using them on a small and large scale to create more individualized treatments that have a greater impact on patient wellness. Using different analytical methods like mass spectrometry and flow cytometry helps researchers identify how quantitative results from these biomarkers can factor into patient treatment options.
Promoting Awareness in the Lab
Experts play vital roles in the lab, both for their insight and their ability to develop robust, sensitive and specific assays for quantifying drugs in human matrices or for measuring biomarkers. However, PRA’s professionals offer more than knowledge and expertise.
Study samples are more than just samples. They’re our connection to patients and the key to treating them. Understanding that relationship is where PRA succeeds in the medical and pharmaceutical industry. Our experts in PRA’s laboratories for drug development use bioanalysis to give patients options while we create a world where they have access to better care.
Peter Ketelaar, VP, Global Bioanalytical Services
“Study samples are more than just samples,” says Peter Ketelaar, VP, Global Bioanalytical Services. “They’re our connection to patients and the key to treating them. Understanding that relationship is where PRA succeeds in the medical and pharmaceutical industry. Our experts in PRA’s laboratories for drug development use bioanalysis to give patients options while we create a world where they have access to better care.”
As an example, the experts at PRA’s Bioanalytical Laboratories have a wealth of experience to help advance medical research with bioanalysis of anti-drug antibody (ADA) assays. They adapt to the industry’s and patients’ needs according to HI*PRA values as the world requires new treatments and technology to support patients.
PRA has two bioanalytical laboratories, based in the Netherlands and in the USA, respectively. But we also work with qualified partner labs across the world. We transfer our bioanalytical methods as required between the US, Europe, and—more recently—two labs in China. This practice allows for the sharing of research and improved methods worldwide to help patients everywhere and ensure our solutions reach farther.
qPCR at PRA’s Laboratories for Drug Development
We see new drug types being studied more and more, such as cell and gene therapies. For some of these drug types, qPCR is a valuable technology to…
State-of-the-art Clinical Facilities
We provide end-to-end bioanalytical support from Pre-clinical to Phase IV studies. At PRA, our laboratories are managed, staffed, and supported by…
PRA Lenexa Lab Celebrates Ten-Year Anniversary
Clinical trial development is experiencing a surge in scientific breakthroughs, thanks to the introduction of new technologies and services. As we…